| Mary K Wehking, RPH | |
|
1 Memorial Dr, Alton, IL 62002-6722 | |
| (618) 463-7833 | |
| (618) 463-7722 |
| Full Name | Mary K Wehking |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1 Memorial Dr, Alton, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740239268 | NPI | - | NPPES |
| 1475385 | Other | IL | NABP NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 042212 (Missouri) | Secondary |
| 183500000X | Pharmacist | (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary K Wehking, RPH 2706 Hunters Rdg, Edwardsville, IL 62025-3062 Ph: (618) 692-4555 | Mary K Wehking, RPH 1 Memorial Dr, Alton, IL 62002-6722 Ph: (618) 463-7833 |
News Archive
Nearly half of all deaths in the United States in 2012 that were caused by cardiometabolic diseases, including heart disease, stroke and type 2 diabetes, have been linked to substandard eating habits, according to a study published in the March 7 issue of JAMA and funded by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.
In the past, multiple sclerosis patients were advised not to exercise for fear of exacerbating the illness. However, it is now known that physical training can relieve many of the symptoms, including the excessive fatigue and mobility impairments that are often seen.
BioDelivery Sciences International, Inc. (BDSI®) (Nasdaq:BDSI) today announced that it has retained ICR, a leading investor relations and strategic advisory firm, to assist in the Company's shareholder communications program. ICR, founded in 1998 by a group of former institutional capital markets professionals, is headquartered in Westport, Connecticut, with offices in Westport, New York, Los Angeles, Boston, Chicago, Minneapolis, Beijing, and Shanghai.
CytomX Therapeutics, a biotechnology company focused on the development of proteolytically activated antibodies, today announced the receipt of two grants totaling more than $488,000 from the Qualifying Therapeutic Discovery Project (QTDP) Program. The grants are directed toward the company's lead preclinical programs targeting colon, head and neck, pancreatic and triple-negative breast cancers and glioblastoma multiforme (GBM).
› Verified 5 days ago
Kaitlin Mioux, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2422 College Ave, Alton, IL 62002 Phone: 618-465-3434 | |
Dr. Ryan David Hemann, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2422 College Ave, Alton, IL 62002 Phone: 618-465-3434 | |
Matthew Schneider, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2422 College Ave, Alton, IL 62002 Phone: 618-465-3434 Fax: 618-465-0034 | |
Dr. Angela Mangi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1650 Washington Ave, Alton, IL 62002 Phone: 618-462-5386 | |
Dr. Kerry Studnicki, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1650 Washington Ave, Alton, IL 62002 Phone: 618-462-5386 | |
Mrs. Mary Lisa Jones, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2 Memorial Drive, Ste 100, Home Care Pharmacy, Alton, IL 62002 Phone: 618-463-7865 Fax: 618-463-7884 | |
Kelly S Mueller, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7425 |